Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Araris Biotech AG Araris a Swiss oncology biotech company developing nextgeneration antibody drug conjugates ADCs today announced they have entered a Research Collaboration and Option to License Agreement
The COVID pandemic has fundamentally transformed global healthcare systems and vaccine technologies The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in infectious disease response highlighting the need for sw...
Boehringer Ingelheim BioXcellence and Sutro Biopharma Inc today announced that they successfully applied Sutros proprietary cellfree expression technology on a commercial scale to manufacture luveltamab tazevibulin luvelta
Biocytogen and Acepodia TT today announced a groundbreaking strategic partnership to jointly assess a dualpayload bispecific antibodydrug conjugate BsADC program
QurisAI an artificial intelligence AI innovator disrupting the pharmaceutical arena today announced that Merck KGaA Darmstadt Germany a leading science and technology company has adopted Quris BioAI clinical prediction platform as part of Merck KGaA...
Alebund Pharmaceuticals an integrated biopharmaceutical company focusing on developing innovative therapies for renal diseases and related chronic conditions announced the closing of RMB million in Series C financing
Insilico Medicine a clinicalstage generative artificial intelligence AIdriven drug discovery and development company today announces positive results from two Phase I studies in Australia and China of ISM a novel gutrestricted and PHD specific
Researchers at the National University of Singapore NUS have developed a noninvasive method to improve the effectiveness of chemotherapy while reducing its harmful side effects
CytoMed Therapeutics Limiteda Singaporebased clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donorderived cellbased allogeneic offtheshelf immunotherapies for the treatment of various cance...
Asieris Pharmaceuticals a leading global biopharmaceutical company dedicated to advancing innovative therapies for genitourinary tumors and womens health with significant unmet medical needs announced the signing of an investigational